Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page
- Check4 days agoChange DetectedAdded extensive Locations sections with study sites across multiple regions (US states, Canadian provinces, Europe, Asia and Australia). Updated the page revision to v3.3.3.SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, which appears to be a minor system update with no changes to core page content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedThe Publications section now notes that publications are provided voluntarily and are automatically filled from PubMed, and the page revision is updated to v3.3.1.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded the study site entry: Tainan, Taiwan 704. Removed the previous listing 'Tainan City, Taiwan 704' and removed the government funding status notice.SummaryDifference0.1%

- Check54 days agoChange DetectedThe study status changed from Active, not recruiting to Completed (as of 2025-10-29).SummaryDifference0.3%

- Check61 days agoChange DetectedAdded Cali, Colombia, 760001 as a study site and removed Santiago de Cali, Colombia, 760001 from the Locations section.SummaryDifference0.1%

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.